NLS Pharmaceutics Ltd. (NASDAQ:NLSP) Short Interest Down 28.2% in March

NLS Pharmaceutics Ltd. (NASDAQ:NLSP) was the target of a significant decrease in short interest in the month of March. As of March 15th, there was short interest totalling 41,800 shares, a decrease of 28.2% from the February 28th total of 58,200 shares. Currently, 2.7% of the shares of the company are sold short. Based on an average daily trading volume, of 2,580,000 shares, the short-interest ratio is presently 0.0 days.

NLS Pharmaceutics Stock Performance

Shares of NASDAQ NLSP traded down $0.23 during midday trading on Friday, reaching $1.30. 44,239 shares of the company were exchanged, compared to its average volume of 837,966. The stock has a fifty day simple moving average of $1.85 and a 200 day simple moving average of $2.53. NLS Pharmaceutics has a 1 year low of $1.30 and a 1 year high of $18.39.

About NLS Pharmaceutics

NLS Pharmaceutics AG, a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies for patients with rare and complex central nervous system disorders. The company is focusing on the development of treatments for narcolepsy, idiopathic hypersomnia, and other rare sleep disorders, as well as neurodevelopmental disorders, such as attention deficit hyperactivity disorder (ADHD).